On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Juste, Ramon A ^a   Elguezabal, Natalia ^a   Garrido, Joseba M ^a   Pavon, Andres ^b   Geijo, Maria V ^a   Sevilla, Iker ^a   Cabriada, Jose Luis ^c   Tejada, Angel ^d   Garcia Campos, Francisco ^e   Casado, Roberto ^b   Ochotorena, Itziar ^b   Izeta, Ander ^b   Greenstein, Robert J ^f  

^a NEIKER and a Vaccine producing Commercial Company CZVSL   (Spain)

^b Fundacion Inbiomed   (Spain)

^c HOSPITAL DE GALDAKAO   (Spain)

^d HOSPITAL QUIRÓN   (Spain)

^e HOSPITAL TXAGORRITXU   (Spain)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMETABOLITE; AZATHIOPRINE; BACTERIAL DNA; CIPROFLOXACIN; INFLIXIMAB; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PREDNISOLONE; SALAZOSULFAPYRIDINE; SALICYLIC ACID DERIVATIVE; STEROID; TACROLIMUS;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BLOOD DONOR; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DNA DETERMINATION; DNA SEQUENCE; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM PARATUBERCULOSIS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEROPREVALENCE; ULCERATIVE COLITIS; BLOOD; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY;

CORYNEBACTERINEAE; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS;

COLITIS, ULCERATIVE; DNA, BACTERIAL; HUMANS; INFLAMMATORY BOWEL DISEASES; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; POLYMERASE CHAIN REACTION;

EID: 49749125560     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002537     Document Type: Article

References (34)

1. Ramaprasad P, Fernando A, Madhale S, Rao JR, Edward VK, et al. (1997) Transmission and protection in leprosy: indications of the role of mucosal immunity. Lepr Rev 68: 301-315.
2. Britton WJ, Lockwood DN (2004) Leprosy. Lancet 363: 1209-1219.
3. 2003 WHO annual report on global TB control-summary. Wkly Epidemiol Rec 78: 122-128.
4. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
5. Johne HA, Frothingham L (1895) Ein eigenthumlicher fall von tuberculose beim rind (A particular case of tuberculosis in a cow). Dtsch Zeitschr Tiermed, Vergl Pathol 21: 438-454.
6. Dalziel TK (1913) Chronic intestinal enteritis. British Medical Journal ii: 1068-1070.
7. Selby W, Pavli P, Crotty B, Florin T, Radford-Smith G, et al. (2007) Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 132: 2313-2319.
8. Greenstein RJ, Collins MT (2004) Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic? Lancet 364: 396-397.
9. Mishina D, Katsel P, Brown ST, Gilberts EC, Greenstein RJ (1996) On the etiology of Crohn disease. Proc Natl Acad Sci U S A 93: 9816-9820.
10. Ellingson JL, Anderson JL, Koziczkowski JJ, Radcliff RP, Sloan SJ, et al. (2005) Detection of viable Mycobacterium avium subsp. paratuberculosis in retail pasteurized whole milk by two culture methods and PCR. J Food Prot 68: 966-972.
11. Grant IR, Hitchings EI, McCartney A, Ferguson F, Rowe MT (2002) Effect of Commercial-Scale High-Temperature, Short-Time Pasteurization on the Viability of Mycobacterium paratuberculosis in Naturally Infected Cows' Milk. Appl Environ Microbiol 68: 602-607.
12. Ayele WY, Svastova P, Roubal P, Bartos M, Pavlik I (2005) Mycobacterium avium subspecies paratuberculosis cultured from locally and commercially pasteurized cow's milk in the Czech Republic. Appl Environ Microbiol 71: 1210-1214.
13. Naser SA, Schwartz D, Shafran I (2000) Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am J Gastroenterol 95: 1094-1095.
14. Naser SA, Ghobrial G, Romero C, Valentine JF (2004) Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364: 1039-1044.
15. Koch R (1882) Die Aetilogie der Tuberculose. Berl, klin, Wschr 19: 221-230.
16. Greenstein RJ (2003) Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 3: 507-514.
17. Stewart-Tull DES (1982) Myobacterium leprae - The bacteriologist's enigma. In: Ratledge C, Stanford J, eds (1982) The Biology of the Mycobacteria, Volume 1: Physiology, Identification, and Classification. 1 ed. New york: Academic Press. pp 273 307.
18. Svartz N (1942) Salazopyrin, a new sulfanilamide preparation. A. Therapeutic Results in Rheumatic Polyarthritis. B. Therapeutic Results in Ulcerative Colitis. C. Toxic Manifestations in Treatment with Sulfanilamide Preparations. Acta Medica Scandinavica 110: 577-598.
19. Greenstein RJ, Su L, Shahidi A, Brown ST (2007) On the Action of 5-Amino-Salicylic Acid and Sulfapyridine on M. avium including Subspecies paratuberculosis. PLoS ONE 2: e516.
20. Greenstein RJ, Su L, Haroutunian V, Shahidi A, Brown ST (2007) On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis. PLoS ONE 2: e161.
21. Shin SJ, Collins MT (2008) Thiopurine drugs (azathioprine and 6-mercaptopurine) inhibit Mycobacterium paratuberculosis growth in vitro. Antimicrob Agents Chemother 52: 418-426.
22. Berardi RR (1996) Inflammatory Bowel Disease. In: Herfindal ET, Gourley DR, eds (1996) Textbook of Therapeutics Drugs and Disease Management. Baltimore: Williams and Wilkins. pp 483-502.
23. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, et al. (1987) FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 40: 1249-1255.
24. Spencer CM, Goa KL, Gillis JC (1997) Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 54: 925-975.
25. Ng SC, Arebi N, Kamm MA (2007) Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease. Inflamm Bowel Dis 13: 129-134.
26. Barrow WW, Wright EL, Goh KS, Rastogi N (1993) Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium. Antimicrob Agents Chemother 37: 652-661.
27. Zanetti S, Molicotti P, Cannas S, Ortu S, Ahmed N, et al. (2006) "In vitro" activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis. Ann Clin Microbiol Antimicrob 5: 27.
28. Prasad K, Volmink J, Menon GR (2000) Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev. pp CD002244.
29. Farinha NJ, Razali KA, Holzel H, Morgan G, Novelli VM (2000) Tuberculosis of the central nervous system in children: a 20-year survey. J Infect 41: 61-68.
30. Chiodini RJ, Van Kruiningen HJ, Merkal RS, Thayer Jr. WR, Coutu JA (1984) Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease. J Clin Microbiol 20: 966-971.
31. Bull TJ, McMinn EJ, Sidi-Boumedine K, Skull A, Durkin D, et al. (2003) Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol 41: 2915-2923.
32. Ivnitski D, O'Neil DJ, Gattuso A, Schlicht R, Calidonna M, et al. (2003) Nucleic acid approaches for detection and identification of biological warfare and infectious disease agents. Biotechniques 35: 862-869.
33. Sampath R, Hall TA, Massire C, Li F, Blyn LB, et al. (2007) Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry. Ann N Y Acad Sci 1102: 109-120.
34. Lindler LE, Fan W (2003) Development of a 5′ nuclease assay to detect ciprofloxacin resistant isolates of the biowarfare agent Yersinia pestis. Mol Cell Probes 17: 41-47.